A podcast on medicine, oncology, & health policy. Host: Vinay Prasad, MD MPH from University of California San Francisco. Tweet your feedback to @Plenary_Session or e-mail plenarysessionpodcast@gmail.com
…
continue reading
Is alcohol healthy for you? I break down everything you need to know about beer, wine, and spirits.Plenary Session
…
continue reading
1
2 HOUR ASH Presentation with AARON GOODMAN & MANNI & More
1:58:16
1:58:16
Відтворити пізніше
Відтворити пізніше
Списки
Подобається
Подобається
1:58:16
Our 2 hour critical appraisal and ASH review. SO many guest starsPlenary Session
…
continue reading
Lecture on systematic review, given by Vinay Prasad MD MPH to students in the UCSF Training in Clinical Research Program, November 2024.Plenary Session
…
continue reading
Timothee Olivier and I discuss the top ESMO 2024 abstracts!Plenary Session
…
continue reading
AI in healthcare - my latest keynote addressPlenary Session
…
continue reading
1
Masking Mistakes - my panel discussion at the Emory Center for Ethics
1:36:47
1:36:47
Відтворити пізніше
Відтворити пізніше
Списки
Подобається
Подобається
1:36:47
"Masking Mistakes: Lessons from the Science, Policy, and Coverage of COVID-19", the 2024 Brian Shields Lecture on Institutional Ethics which took place on Monday, October 7, 2024 for the Emory Center for Ethics. A conversation with Carlos Del Rio, MD and Vinay Prasad, MD MPH with moderation by Gerard Vong, DPhil, Director of the MA in Bioethics pro…
…
continue reading
Screening/ Drug efficacy/ Sotorasib/ Adaura and morePlenary Session
…
continue reading
My UCSF lecture on driver mutation lung cancerPlenary Session
…
continue reading
We break down the best studies from ASCOPlenary Session
…
continue reading
1
Critical Appraisal - My 2 hour ASCO lecture - Day 2 version
1:54:09
1:54:09
Відтворити пізніше
Відтворити пізніше
Списки
Подобається
Подобається
1:54:09
Critical Appraisal - My 2 hour ASCO lecture - Day 2 version by Plenary SessionPlenary Session
…
continue reading
What you need to know in advance of ASCOPlenary Session
…
continue reading
Should trials have carbon footprint as an endpoint?Plenary Session
…
continue reading
My grand rounds; Beta blockers post MISingle center vs multicenter RCTMasksBoosters and morePlenary Session
…
continue reading
I crossover SM podcast; Harvard med students video, Justice curriculum, Masking half the yearPlenary Session
…
continue reading
Patient advocates, Pharma funding, and is MRD a suitable endpointPlenary Session
…
continue reading
5 reasons that is a bad ideaPlenary Session
…
continue reading
Another flawed quality metric. Reviewing the NEJM paper "Beta-Blockers After Myocardial Infarction and Preserved Ejection Fraction".Plenary Session
…
continue reading